(Q41469895)

1 October 2017

Treatment response in Paget's disease (English)

1 reference

1 October 2017

Patel S

1

1 reference

PMC publication ID

1010006

1 October 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

Annals of the Rheumatic Diseases

1 October 2017

1 reference

1 October 2017

54

1 reference

1 October 2017

10

1 reference

1 October 2017

783-784

1 reference

Effects of two different bisphosphonates on Paget's disease of bone: ICTP assessed

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010006

Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010006

Long-term follow-up observations on treatment in Paget's disease of bone

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010006

Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010006

Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010006

Advances in the management of Paget's disease of bone

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010006

Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010006

Clinical review 39: Paget's disease of bone

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010006

Effects of two oral doses of alendronate in the treatment of Paget's disease of bone

11 June 2018

1 reference

12 December 2020

Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy

1 reference

12 December 2020

Duration of effect of oral diphosphonate therapy in Paget's disease of bone

1 reference

12 December 2020

Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment

1 reference

12 December 2020

Bone scintigraphy following intravenous pamidronate for Paget's disease of bone

1 reference

12 December 2020

Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?

1 reference

12 December 2020

Determinants of remission of Paget's disease of bone

1 reference

12 December 2020

Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.54.10.783

1 reference

1 October 2017

1 reference

PMC publication ID

1010006

1 October 2017

PubMed publication ID

7492213

1 reference

PMC publication ID

1010006